HEXAHYDRO-3,4,6,6-TETRAMETHYL-7-(4-MORPHOLINYL)-2-PHENYL-1,4-OXAZEPINE
UNII QIK32GGV5T

Substance Identification & Data

This profile provides standardized clinical and technical data for Hexahydro-3,4,6,6-tetramethyl-7-(4-morpholinyl)-2-phenyl-1,4-oxazepine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QIK32GGV5T.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 76503-78-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QIK32GGV5T

CAS Registry Number

76503-78-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

HEXAHYDRO-3,4,6,6-TETRAMETHYL-7-(4-MORPHOLINYL)-2-PHENYL-1,4-OXAZEPINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H30N2O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MOSYSGPJTJMMDV-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

434340

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1(C(CN(C)C(C(O1)c2ccccc2)C)(C)C)N3CCOCC3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Hexahydro-3,4,6,6-tetramethyl-7-(4-morpholinyl)-2-phenyl-1,4-oxazepine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.